| pubmed-article:19410951 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C0154830 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C0521141 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C0040866 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
| pubmed-article:19410951 | lifeskim:mentions | umls-concept:C1363844 | lld:lifeskim |
| pubmed-article:19410951 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19410951 | pubmed:dateCreated | 2009-5-4 | lld:pubmed |
| pubmed-article:19410951 | pubmed:abstractText | To evaluate vitreous vascular endothelial growth factor (VEGF), stromal cell-derived factor 1alpha (SDF-1alpha), interleukins (ILs), and tumor necrosis factor-alpha (TNF-alpha) after intravitreal bevacizumab or triamcinolone acetonide (TA) in eyes with proliferative diabetic retinopathy (PDR). | lld:pubmed |
| pubmed-article:19410951 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19410951 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19410951 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19410951 | pubmed:month | May | lld:pubmed |
| pubmed-article:19410951 | pubmed:issn | 1549-4713 | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:MaruyamaIkuro... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:HashiguchiTer... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:SakamotoTaiji... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:NodaYoshihiro... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:NakaoShintaro... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:YamakiriKeita... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:SonodaYasushi... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:ArimuraNoboru... | lld:pubmed |
| pubmed-article:19410951 | pubmed:author | pubmed-author:OtsukaHirokiH | lld:pubmed |
| pubmed-article:19410951 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19410951 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:19410951 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19410951 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19410951 | pubmed:pagination | 921-6 | lld:pubmed |
| pubmed-article:19410951 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:meshHeading | pubmed-meshheading:19410951... | lld:pubmed |
| pubmed-article:19410951 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19410951 | pubmed:articleTitle | Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. | lld:pubmed |
| pubmed-article:19410951 | pubmed:affiliation | Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. | lld:pubmed |
| pubmed-article:19410951 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19410951 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19410951 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19410951 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19410951 | lld:pubmed |
